Javascript must be enabled to continue!
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
View through CrossRef
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rAAV9-PDGF-B) transduction to rat cardiomyocytes in vitro.
Methods
The primary neonatal rat cardiomyocytes were isolated and cultured, and cardiomyocytes were transduced with rAAV9-PDGF-B at MOI (multiplicities of infection) = 5 × 105, and collected cardiomyocytes from different times after transduction, respectively at1, 3, 6, 14, 21, 28 days. Proteins were extracted from the cells for Western Blot analyse and observed the expression of PDGF-B, the transfection efficiency were measured by cell immunofluorescence. Alamar Blue assays were used to evaluate the safety of rAAV9-PDGF-B transduction to cardiomyocytes. And explore the cardiomyocytes which over expressed PDGF-B whether own the capacity of protecting cells against H2O2 –induced apoptosis by the test of apoptosis-related proteins and the ratio of Tunel-positive cell.
Results
Cardiomyocytes were over expressed PDGF-B at the third day after transduction, and the expression of PDGF-B was increased gradually. After days 5, the expression would be stable and sustaining, such expression can last for 28 days. Cell immunofluorescence showed that approximately 78.6% cardiomyocytes overexpressed PDGF-B at days 6 after transduction. Alamar Blue assays, which evaluated the toxicity of rAAV9-PDGF-B transduction to cardiomyocytes, showed that the reduction ratios of cardiomyocytes at different times were all close to 1.0. Moreover, in Cardiomyocytes which over expressed PDGF-B, H2O2 –induced apoptosis was accompanied by the down-regulation of Bax and Tunel-positive cells, by the up-regulation of Bcl-2 and P-Akt, there was no difference between group PDGF-B+ H2O2 (P > 0.05).
Conclusions
rAAV9-PDGF-B could effectively transduce cardiomyocytes cultured in vitro and persistently express PDGF-B at least 28 days. rAAV9-PDGF-B was no significant toxic effects on cardiomyocytes. Furthermore, the cardiomyocytes which over expressed PDGF-B also own the capacity of protecting cells against H2O2 –induced apoptosis, these effects might be mediated by phosphorylation of Akt signalling in cardiomyocytes.
Title: ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
Description:
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rAAV9-PDGF-B) transduction to rat cardiomyocytes in vitro.
Methods
The primary neonatal rat cardiomyocytes were isolated and cultured, and cardiomyocytes were transduced with rAAV9-PDGF-B at MOI (multiplicities of infection) = 5 × 105, and collected cardiomyocytes from different times after transduction, respectively at1, 3, 6, 14, 21, 28 days.
Proteins were extracted from the cells for Western Blot analyse and observed the expression of PDGF-B, the transfection efficiency were measured by cell immunofluorescence.
Alamar Blue assays were used to evaluate the safety of rAAV9-PDGF-B transduction to cardiomyocytes.
And explore the cardiomyocytes which over expressed PDGF-B whether own the capacity of protecting cells against H2O2 –induced apoptosis by the test of apoptosis-related proteins and the ratio of Tunel-positive cell.
Results
Cardiomyocytes were over expressed PDGF-B at the third day after transduction, and the expression of PDGF-B was increased gradually.
After days 5, the expression would be stable and sustaining, such expression can last for 28 days.
Cell immunofluorescence showed that approximately 78.
6% cardiomyocytes overexpressed PDGF-B at days 6 after transduction.
Alamar Blue assays, which evaluated the toxicity of rAAV9-PDGF-B transduction to cardiomyocytes, showed that the reduction ratios of cardiomyocytes at different times were all close to 1.
Moreover, in Cardiomyocytes which over expressed PDGF-B, H2O2 –induced apoptosis was accompanied by the down-regulation of Bax and Tunel-positive cells, by the up-regulation of Bcl-2 and P-Akt, there was no difference between group PDGF-B+ H2O2 (P > 0.
05).
Conclusions
rAAV9-PDGF-B could effectively transduce cardiomyocytes cultured in vitro and persistently express PDGF-B at least 28 days.
rAAV9-PDGF-B was no significant toxic effects on cardiomyocytes.
Furthermore, the cardiomyocytes which over expressed PDGF-B also own the capacity of protecting cells against H2O2 –induced apoptosis, these effects might be mediated by phosphorylation of Akt signalling in cardiomyocytes.
Related Results
Effect of Imatinib on Proliferation, Apoptosis and Expression of Platelet Derived Growth Factor Receptor By Mesenchymal Stem Cells
Effect of Imatinib on Proliferation, Apoptosis and Expression of Platelet Derived Growth Factor Receptor By Mesenchymal Stem Cells
Abstract
Introduction
Imatinib Mesylate (IM) is a tyrosine kinase inhibitor (TKI), which targets Platelet Derived Growth Factor Receptor (PDGF-R), c-k...
Functional Regulation of Adipose-Derived Stem Cells by PDGF-D
Functional Regulation of Adipose-Derived Stem Cells by PDGF-D
Abstract
Platelet-derived growth factor-D (PDGF-D) was recently identified, and acts as potent mitogen for mesenchymal cells. PDGF-D also induces cellular transforma...
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
Abstract
Background: Essential Thrombocythemia (ET) is characterized by persistently elevated platelet counts in the context of a normal red cell mass. However, the ...
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 9 WITH RIBOZYME GENE TARGETING NF-κB AND ITS SUPPRESSION OF NF-κB ACTIVITY IN HELA CELLS
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 9 WITH RIBOZYME GENE TARGETING NF-κB AND ITS SUPPRESSION OF NF-κB ACTIVITY IN HELA CELLS
Objectives
To construct the recombinant adeno-associated virus serotype 9 containing ribozyme gene (R65) targeting nuclear factor-κ B (NF-κB), and investigate the...
Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells
Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells
AbstractWe have compared the biological and biochemical properties of recombinant PDGF AA, AB, and BB using three types of fibroblastic cells: NIH/3T3, human skin fibroblast, and f...
Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity
Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity
AbstractProtamine sulfate blocked 125I‐PDGF binding to its specific physiological receptor on Swiss mouse 3T3 cells. Reduced 125I‐PDGF binding in the presence of protamine sulfate ...
The platelet‐derived growth factor isomers, PDGF‐AA, PDGF‐AB and PDGF‐BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms
The platelet‐derived growth factor isomers, PDGF‐AA, PDGF‐AB and PDGF‐BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms
The effect of human recombinant platelet‐derived growth factor (PDGF) isoforms, (r)PDGF‐AA, PDGF‐AB and PDGF‐BB, on contractility of rat aortic rings as well as on intercellular fr...

